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1. Introduction  
In recent years, genetically modified (GM) plants, whose DNA has been changed using 
genetic engineering techniques, are mainly used as foods for human and feeds and foods for 
farm animals. To date, a number of GM products have been approved for human 
consumption but concerns over safety persist, mainly as regards either the detection of 
transgenic plant genes and proteins in animal systems or allergenicity and toxicity of GM 
plants.  
Since their commercial release in 1996, the global cultivation area dedicated to the 
production of GM plants has increased significantly (ISAAA, 2010). The majority of GM 
crops currently produced, like soybean, corn, cotton and canola, have been engineered to 
enhance agronomic performance by transformation with genes encoding herbicide tolerance 
and pest resistance. GM soybean has been rendered tolerant to the glyphosate family of 
herbicides through expression of transgenic DNA from the CP4 strain of Agrobacterium 
tumefaciens that encodes 5-enolpyruvylshikamate-3-phosphate synthase (CP4 EPSPS). 
Roundup Ready (RR) soybean have been grown commercially from 1996 and continued to 
be the principal biotech crop in 2010. Farm animals are currently fed soybean and soybean 
meal developed from genetic transformation as well as corn and corn products. The 
European Union imports soybean from USA, Brazil, and Argentina, the main users of 
biotech crops globally. About 90% of the compound feed produced in the EU contains GM 
soybean.  
Although regulations with regard to GM plants have been developed primarily from the 
perspective of human consumption of GM food, it is generally assumed that these criteria 
are suitable for a risk assessment of the consumption of GM feed by livestock. The protocol 
for establishing “substantial equivalence” of GM plant compared to isogenic parental lines 
does not complete a nutritional safety assessment of a GM plant, rather, it provides a 
starting point for the overall assessment (FAO/WHO, 2000). Based on the European novel 
food and feed regulation, all foods and feeds containing or derived from approved GM 
products in amounts greater than a 0.9% threshold are subject to labelling rules (European 
Commission, 2003). Labelling of feeds containing GM ingredients gives farmers the choice 
of using such feed for their livestock. However, products such as milk, meat, and eggs, that 
are derived from livestock fed transgenic feeds are exempt from EU-labelling laws. Several 
studies have been conducted to evaluate the safety of GM crops, but there is still a debate on 
the risk of GM consumption and their potential passage into tissues.  
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Current researches suggest that the passage of plant DNA fragments across the intestinal 
barrier is a natural event, as demonstrated by the detection of endogenous, high copy 
number chloroplast genes from plants in several animal tissues and products. Low copy 
endogenous and transgenic DNA in animal tissues have been detected but to a lesser extent 
than high copy genes.  
For several years, no direct evidence that GM food may represent a possible danger for 
health has been reported and the scientific literature in this field is still quite poor, especially 
as to the possible effect of a diet involving a significant amount of GM plants. More recently, 
a number of papers have been published and controversial results have been obtained. 
However, some have found significant modifications in some nuclear features in mice fed 
GM soybean and, more recently, it has been reported that the activity of some enzymes was 
altered in rabbit and goats fed GM soybean, as confirmed also by histochemistry which 
showed a widespread distribution of enzyme activity in myocytes, myocardiocytes, 
epithelial cells of renal tubules and hepatocytes. These observations suggest that the risk of 
genetically modified crops cannot be ignored and requires further investigations in order to 
identify possible long-term effects of GM plants on both livestock and human consumption. 
The main focus of this chapter concerns the genetically engineered soybean, its effects on 
human and animal health, the productivity of this GM crop and the outcome for 
environment. 
2. Agronomic impact of genetically modified soybean  
Genetic engineering has been widely applied to agriculture to obtain specific plant 
characteristics which can lead to an improvement in both food quality and yield. Compared 
with traditional plant breeding methods, such as artificial crossing or hybridization, 
biotechnology now allows for the introduction of DNA from outside the plant kingdom. 
Selective inclusion of single or multiple traits can be performed to change the quality of 
agricultural crops. According to statistics released by the International Service for the 
Acquisition of Agri-Biotech Applications (ISAAA, 2010), the area of planted transgenic 
crops was 148 million hectares in 2010, a approximately 87-fold increase from the 1996 level 
(1.7 million hectares of biotech crops). The number of countries adopting biotech crop 
cultivation has increased crops consistently from 6 in 1996 to 29 in 2010. The Unites States 
(US), followed by Brazil, Argentina, India, Canada, and China continued to be the principal 
adopters of biotech crops globally, with 66.8  million hectares planted in the US.  
The majority of genetically modified (GM) crops currently produced have been engineered 
to enhance agronomic performance by transformation with genes encoding herbicide 
tolerance or pest resistance. From the first commercialization of biotech crops in 1996, to 
2010 herbicide tolerance has consistently been the dominant trait. In 2010, herbicide 
tolerance deployed in soybean, corn, canola, cotton, sugarbeet and alfalfa, occupied 61% or 
89.3 million hectares of the global biotech area. In 2010, the stacked double and triple traits 
occupied a larger area (22% or 32.3 million hectares) than insect resistant varieties (26.3 
million hectares) at 17%. The insect resistance trait products were the fastest growing trait 
group between 2009 and 2010 at 21% growth, compared with 13% for stacked traits and 7% 
for herbicide tolerance.  
Biotech herbicide tolerant soybean continued to be the principal biotech crop in 2010, 
occupying 73.3 million hectares or 50% of global biotech area, followed by biotech corn (46.8 
million hectares at 31%), biotech cotton (21.0 million hectares at 14%) and biotech canola (7.0 
million hectares at 5%) of the global biotech crop area. 
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Farm animals are currently fed soybean and soybean meal developed from genetic 
transformation as well as corn and corn products such as corn gluten feed and meal. Europe 
is strongly dependent upon the American continent for its protein requirements amounting 
up to 90 to 95% for soybean, 40 to 60% for corn derivatives and partly for canola grain or 
meal (Aumaitre, 2004).  
3. Genetic modification of soybean 
Traditionally, plants with desirable characteristics were chosen for food of the next 
generation. The desirable characteristics arose from naturally occurring variations in the 
genetic make-up of individual plants. Unlike conventional genetic modification that is 
carried out through time-tested conventional breeding of plants as combining genes from 
different organisms is known as recombinant DNA technology and the resulting organism 
is said to be genetically modified, or genetically engineered or transgenic (Pandey et al., 
2010). 
Transgenic plant is one that has received a segment of DNA or genes from another organism 
(known as heterologous or foreign DNA) using recombinant DNA techniques. The foreign 
DNA is integrated through natural systems present in plant cells into the plant’s genome. 
The newly introduced genes are subsequently inherited in a normal Mendelian manner 
through pollen and egg cells. The mainly process of introducing DNA into plants (called 
transformation) uses the Agrobacterium mediated method and it can be achieved both in 
monocotyledonous plants such as wheat, barley and rice and in dicotyledonous plants such 
as soyabean, potato and tomato. 
The soil bacterium Agrobacterium tumefaciens causes crown gall disease on some plants, in 
particular in dicotyledonous species. In causing crown gall disease A. tumefaciens transfers 
DNA (the transferred DNA or T-DNA) from the bacterium to the plant. In nature the 
transferred bacterial DNA cause the symptoms associated with crown gall disease. In the 
early 1980s scientists removed the disease causing genes from this bacterium and the T-
DNA is now routinely used to transport foreign genes into plants. Agrobacterium cells 
carrying the foreign genes of interest are incubated with cultured cells of the recipient crop 
plant and transgenic plants are regenerated from them. Not all cells subjected to this process 
are successfully modified so it may be necessary to identify the modified cells using marker 
genes which are closely linked to the genetic material that is transferred. These selectable 
marker genes usually confer resistance to an antibiotic such as kanamycin or resistance to an 
herbicide. 
The genetically modified soybean (named RoundUp Ready, RR) has been rendered tolerant 
to the glyphosate family of herbicides through expression of transgenic DNA from 
Agrobacterium tumefaciens sp. strain CP4 that encodes 5-enolpyruvylshikamate-3-phosphate 
synthase (CP4 EPSPS). The CP4 EPSPS protein expressed in GE glyphosate tolerant plants is 
functionally equivalent to endogenous plant EPSPS enzymes with the exception that CP4 
EPSPS displays reduced affinity for glyphosate (Franz et al. 1997). This soybean is, also, 
composed of a 35S promoter from cauliflower mosaic virus (CMV) and a NOS-terminator, a 
terminator of nopaline synthase gene.  
According to the Center for Environmental Risk Assessment (2010), the 5-
enolpyruvylshikimate-3-phosphate synthase (EPSPS: EC 2.5.1.19) family of enzymes is 
ubiquitous in plants and microorganisms. EPSPS enzymes have been isolated from both 
sources, and their properties have been extensively studied. EPSPS proteins catalyze the 
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transfer of the enolpyruvyl group from phosphoenol pyruvate (PEP) to the 5-hydroxyl of 
shikimate-3-phosphate (S3P), thereby yielding inorganic phosphate and 5-
enolpyruvylshikimate-3-phosphate (Alibhai and Stallings, 2001). Shikimic acid obtained is a 
substrate for the biosynthesis of aromatic amino acids (phenylalanine, tryptophan and 
tyrosine) as well as many secondary metabolites, such as tetrahydrofolate, ubiquinone, and 
vitamin K. Importantly, the shikimate pathway and, hence, EPSPS proteins, are absent in 
mammals, fish, birds, reptiles and insects (Alibhai and Stallings, 2001). In contrast, it has 
been estimated that aromatic molecules, all of which are derived from shikimic acid, 
represent 35% or more of the dry weight of a plant (Franz et al. 1997). 
 
 
Fig. 1. Schematic representation of glyphosate mode of action and mechanism of CP4 EPSPS 
mediated tolerance (Center for Environmental Risk Assessment, 2010). 
4. Nutritional assessment of genetically modified soybean 
In animal nutrition, many studies with GM plants were carried out in target species using 
the substantial equivalence method. The application of this method to animal studies led to 
the development of the concept of nutritional equivalence which implies specific 
measurements regarding animal production. The European Commission has a combined 
safety approach that requires an assessment of risks for humans, animals, and the 
environment prior to approval of importation or cultivation of a novel crop (European 
Commission, 2001). An integral part of the safety evaluation of GM plants is to test for 
“substantial equivalence”. The concept of substantial equivalence is the starting point and 
guiding concept for safety assessment (Food and Agriculture Organization/World Health 
Organization, 2000). It is not the conclusion, but it is part of the safety assessment (Konig et 
al., 2004; Kuiper & Kleter, 2003). The aim of such a test is to determine whether a transgenic 
plant is substantially equivalent to its conventional counterpart at a chemical and nutritional 
level. While the parameters to be measured have not been formally defined, minimal 
analyses performed should determine whether the major nutritional components (i.e., lipids, 
carbohydrates, proteins, vitamins, minerals, trace elements) and known antinutrients and 
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toxins of transgenic plants are equivalent to those in conventional varieties that have a 
history of safe use. Guidelines have been established by several organizations regarding 
assessment of the allergenic risk of each novel protein expressed in a GM plant, prior to 
market approval (FAO/WHO, 2000; Konig et al., 2004; Martens, 2000). These typically 
include comparison of amino acid sequence homology of the novel protein to known 
allergens and digestion of the protein in simulated gastric environments. While allergic 
reactions are primarily a concern for human consumption of GM foods, certain proteins in 
soybean have been shown to elicit allergenic reactions in calves and piglets. The assessment 
of the safety of GM organisms addresses both intentional and unintentional effects that may 
result as a consequence of genetic engineering of the food source. Future transgenic crops 
are expected to contain fewer or no marker genes in the final products since marker free 
insertion techniques or methods to eliminate marker genes from transgenic plants are being 
improved. The assessment of safety measures are a lengthy and tedious process (Figure 2). 
The nutritional aspects, risk characterization and exposure assessment are preliminary steps 
being taken. Before hitting the market, all GM products have to pass all the allergic tests and 
provide the details. Only those products find as possessing no harmful or allergic effects are 
only recommended. 
 
 
Fig. 2. Pre-market safety and nutritional testing of genetically modified plant derived food 
and fed (EFSA, 2008).   
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In most countries authorities and agencies involved in feed/food safety assessment have 
based their safety assessment strategies and guidelines on this approach. To provide 
consumers the opportunity for choice, in 2004 the European Union (EU) has extended 
regulations concerning GM foods to include animal feeds and feed additives. According to 
Regulation (EC) No. 1829/2003 (European Commission, 2003), all foods and feeds 
containing or derived from approved GM products in amounts greater than a 0.9% 
threshold are subject to labelling rules. Labelling of feeds containing GM ingredients 
informs farmers and gives them the choice of using such feed for their livestock. However, 
products such as milk, meat, and eggs, that are derived from livestock fed transgenic feeds 
are exempt from EU-labelling laws. One of the controversies, important for safety aspects of 
GM feeds, is a potential possibility of transfer of the transgenic DNA to animal tissues, and 
in consequence its negative effect on consumers of such products originating from animals 
fed diets containing GM plants. Detailed studies of the feeding qualities of GM plants for 
livestock and their nutritional evaluation have been reviewed previously (Aumaitre et al., 
2002; Flachowsky et al., 2005a; Flachowsky & Aulrich, 2001). A lot of animal studies with 
GM plants aimed to evaluate the compositional and nutritional equivalency of transgenic 
feeds and their conventional counterparts.  
Accordingly to the substantial equivalence theory, feed chemical analyses were performed 
to determine whether the macronutrients, vitamins, minerals and even trace elements were 
found at the same level as in the conventional or isogenic plants.  The composition studies 
confirmed the substantial equivalence of genetically modified (GM) soybean to conventional 
counterpart (Table 1) (Cromwell et al., 2001; Padgette et al., 1996).  
 
 Conventional soybean GM soybean 
Dry Matter 90.30 91.00 
Crude Protein 51.50 51.20 
NDF 4.95 4.85 
Lysine 3.16 3.09 
Methionine+Cysteine 1.47 1.51 
Table 1. Chemical composition (% dry matter) of genetically modified soyabean (RoundUp 
Ready, RR) and its conventional counterpart (Adapted from Cromwell et al., 2001). NDF: 
neutral detergent fiber. 
The concerns that have been raised with respect to the potential risk associated with the use 
of GM plant products in animal feed are related to the possible unintended effects of 
inserting novel DNA into the plant by biotechnology. The possible “side effects” of the 
genetically modiﬁcation is often termed unintended effects and may result from the random 
integration in the genome of the novel DNA which may result in an over-expression in the 
plant of inherently toxic substances such as anti-nutritional factors (ANFs), silencing of 
endogenous plant genes (e.g essential nutrients), or alterations in host metabolic pathways 
(Novak & Hasleberger 2000;  Saxena & Stotzky, 2001). The possible combination of an 
unexpected increase in expression of endogenous ANFs and the presence of new exogenous 
toxicants have been of particular concern as these could compromise the quality of 
feedstuffs and may affect animal health and nutrition (Francis et al., 2001). Studies also 
include any known anti-nutritional factors (ANFs), such as trypsin inhibitors in soybean, 
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interfering with nutrient absorption or natural toxicants typically present in the genus 
(Padgette et al., 1996). Trypsin inhibitors are similarly destroyed during heating associated 
with oil extraction and preparation of soybean meal. In addition, the activity of urease 
measured by the variation in pH is efficiently reduced by heat treatment whatever the 
genotype of the soybean kernel (Table 2).  
 
 Parental soybean RR 
 Raw Meal Raw Meal 
Lectins (HU/mg sample) 1.2 - 1.0 - 
Trypsin inibithor (TIU/mg 
sample) 
22.6 3.4 23.7 3.3 
Urease (pH) 2.18 0.03 2.17 0.04 
Table 2. Main anti-nutritional factors in raw soybean and soybean meal (parental vs. RR): 
absence of effect of genetic modification for glyphosate resistance (Adapted from Padgette 
et al., 1996). 
Additional nutritional data can be of importance in the case of oil seeds or oil-rich cereals 
such as corn because they can markedly affect the composition of fatty tissues when fed to 
farm animals. Data obtained from the analysis of corn kernels demonstrated similar 
proportions of fatty acids in oil of kernels of insect resistant and herbicide-resistant corn. 
Similarly, and in the majority of cases, it has also been observed that insect resistant and 
herbicide-tolerant corn kernels contain similar proportions of amino acids. The introduction 
of Bt and herbicide tolerance genes in corn has never been found to create starch 
modifications expressed as the proportion of amylose and amylopectin. Thus similar 
proportions of 21.5 and 21.0% of amylose have been found in Bt and herbicide-tolerant 
modified corn, respectively, compared to 22.4 and 22.7% of amylose in starch of the isogenic 
varieties, respectively (Benetrix, 2000). Data from the literature have many times 
corroborated the substantial equivalence in major nutrients and minerals and trace elements 
in corn and kernels of GM compared to isogenic control corn (Brake & Vlachos, 1998; Sidhu 
et al., 2000). The whole modified corn plant (Clarke & Ipharraguerre, 2001; Faust, 2000) has 
also been found to be substantially equivalent in composition to isogenic plants. All these 
data suggest a similar nutritional value for the feed material derived from the modified 
plants (Aumaitre et al., 2002).  
In order to evaluate the nutritive value of feeds for ruminants, nowadays the in vitro gas 
production technique (Theodorou et al. 1994) (IVGPT) is commonly used.  IVGPT is based 
on the assumption that the accumulated  gas production by a substrate, incubated in with 
rumen liquor, is proportional to the amount of digestible carbohydrates, and thus highly 
correlated to the energy value of feeds. In addition, IVGPT allows to study also the 
fermentation kinetics of feeds. Tudisco et al. (2004) in a research, aimed to compare the 
fermentation kinetics of Roundup Ready defatted soybean to its  conventional counterpart 
by the IVGPT, found that the genetic modification, although did not affect the chemical 
composition, led to a significantly lower cumulative gas production and volume per gram of 
incubated organic matter. It could be hypothesized that the genetic modification may lead to 
pleiotropic effects (effect of a single gene on multiple phenotypic traits) that may alter the 
starch and/or protein structure. Alternatively, the results could be explained with a plant 
DNA transfer to ruminal bacteria which may modify their fermentation activity.  
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In any case, the results of this research arouse concerns in term of food safety, because other 
unpredictable metabolic effects, such as metabolic interferences, or direct or indirect 
insertional mutagenesis cannot be excluded. With this regards Seralini et al. (2011) report 
that by insertion of the transgene in varieties producing Cry1Ab toxin caused a complex 
recombination event, leading to the synthesis of new RNA products encoding unknown 
proteins, or/and to metabolic pathways variations which caused up to 50% changes in 
measured osmolytes and branched aminoacids.  
4.1 Nutritional testing of GM feed with GM soybean in target animal species  
Many studies with GM plants were carried out in target species to assess the nutritive value 
of the feed and their performance potential and were revealed no significant differences in 
performance indices and quality parameters of meat, eggs or milk, when farm animals were 
fed diets containing GM or conventional feeds (Aumaitre et al., 2004; Flachowsky et al., 
2005a; Świątkiewicz S. & Świątkiewicz M., 2009). These studies have focused on livestock 
nutrition, in order to confirm nutritional equivalence and to obtain further information 
concerning the safety of animal products.  
As regards monogastric livestock, many feeding studies with 1-day-old broiler chicks have 
been reported (EFSA, 2008), including GM lines of corn, soybean, canola and wheat and 
appropriate counterparts. Few experiments are available with laying hens (Aulrich et al., 
2001; Halle et al., 2006) where GMOs were compared with near isogenic counterparts. 
McNaughton et al. (2011) compared the nutritional performance of laying hens fed corn 
grain (event DP-Ø9814Ø-6) and processed soybean meal (event DP-356Ø43-5), individually 
or in combination, with the performance of hens fed diets containing conventional corn and 
soybean meal. The performance (body weight, feed intake and egg production) and egg 
quality of hens fed GM feeds was comparable with that of hens fed diets formulated with 
conventional feed. In each study, chemical composition and nutritional value of GM lines 
and the near-isogenic non-GM lines were found to be comparable without biologically 
significant differences in the production parameters measured. Experiments with growing 
and laying quails were carried out to test diets with isogenic or GM Bt 176 corn (Flachowsky  
et al., 2005b; Halle et al., 2006). Health, hatchability and performance of quails and the 
quality of meat and eggs were unaffected by the diets. Improvements in livestock 
performance were noted significant with the diet containing Bt corn compared to diets 
containing conventional corn grain (Piva et al., 2001a, 2001b). The authors attributed the 
results to the fact that the use of Bt lines reduced secondary fungal infection and, as a 
consequence, reduced mycotoxin contamination.  Research conducted with growing and 
finishing pigs (EFSA, 2008) including GM corn grain, sugar beet, soybean meal, rapeseed 
meal, rice and wheat, showed that when compositional analyses of GM lines and the near-
isogenic non-GM line and commercial varieties were comparable, then nutritional 
equivalence was also established.  
As regards ruminants, comparable performance of beef cattle fed corn grain, corn silage or 
stover from GM plants or from conventional plants is reported, and in dairy cows the 
inclusion in the diet of feed ingredients derived from a wide range of GM plants unaffected 
feed intake, milk yield and composition (EFSA, 2008). Milk quality is generally measured as 
the fat, protein and lactose concentration and as such there is no evidence to suggest that the 
inclusion of GM feed ingredients affects milk quality. As with other livestock species, 
studies with lactating dairy cows also showed that once compositional equivalence was 
demonstrated then nutritional equivalence occurred.  
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Finally, the production studies carried out with fish provided similar conclusions to those 
drawn from studies conducted with other livestock species (EFSA, 2008).  
 
 Parameters Results References 
Poultry BWG, ADG, FCR, muscle weight 
No significant 
differences 
 
(Hammond et 
al., 1996) 
Pig 
BWG, DMI, FCR, carcass quality, 
sensory score of meat 
No significant 
differences 
(Cromwell et al., 
2001) 
Cow 
Milk yield and composition, DMI, 
nitrogen balance, rumen VFA 
composition 
 
No significant 
differences 
(Hammond et 
al., 1996) 
Table 3. Some experiments carried out to establish the qualitative and quantitative 
performance of monogastric or ruminant livestock fed with GM soybean. BWG: Body 
Weight Gain; ADG: Average Daily Gain; FCR: Feed Conversion Ratio. 
5. Fate of transgenic DNA and new protein in animal organs and products 
One of the most important questions about the use of GM products in animal nutrition is the 
possibility that modified DNA could be transferred from plants to animal products or to 
bacteria, with harmful consequences (FAO, 2004). Other problems regard the ability of 
transgenic proteins to provoke food intolerance or allergic reaction in susceptible people. 
Hence, it is necessary to consider the destiny of these molecules within the animal organism 
(Alexander et al., 2007).  
The gastrointestinal tract is constantly exposed to DNA that is released from partially or 
completely digested food, ingested microbes, and DNA from intestinal microflora. Ingested 
food is mechanically disrupted and the released DNA, although poorly digested, is cleaved 
through acid hydrolysis and enzymatic digestion into small DNA fragments. Eventually 
some of these fragments are converted to single nucleotides. Acid hydrolysis in the 
gastrointestinal tract is expected to depurinate most adensine and guanine nucleotides of 
the food DNA (Klinedinst & Drinkwater, 1992). The presence of various phosphatases and 
deaminases continue to destroy the structural integrity of any free DNA. The breakdown 
products of DNA are absorbed for using at the cellular level for synthetic processes as they 
may be found in blood and tissues (McAllan, 1982). All though there were conflicting 
reports on the fate of GM DNA in the biological system it was observed that DNA could 
pass through the gut wall into the blood stream and taken up by cells in the blood, liver, 
spleen and passed through the placenta to the cells of the feoetus and the newborn one 
(Doerfler & Schubert, 1998).  
In ruminants, experimental evidence suggests that more than 80% of DNA is completely 
disrupted after 2 hours (Wiedemann et al., 2006). However, this degradation is not complete 
and not immediate (van den Eede et al., 2004).  
In animal tissues some fragments of chloroplast DNA have been found. The reason why 
chloroplast DNA is more frequently detected in animal products is the number of the genes 
involved and the sensitivity of the PCR method. In transgenic plants, every cell contains 
hundreds chloroplast genes, but only one transgenic gene (Aumaitre et al., 2002).  
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Research on the fate of foreign DNA in the mammalian organism showed that PCR 
products specific to foreign DNA could be detected therein. It was concluded that DNA 
fragments from the gastrointestinal tract could reach the bloodstream and be transported 
through the epithelium of the gut and the cells of the Peyer’s patches to spleen and liver 
cells. Such DNA fragments are probably retained for a short while and then digested 
(Schubbert et al., 1994, 1997, 1998). While the intestinal tract does not seem an absolute 
barrier against the uptake of macromolecules or even of microorganisms, the mechanism of 
foreign DNA uptake by the intestinal wall epithelia is unknown. In addition, not much is 
known about the degradation and integration of the DNA. There is some evidence that 
fragments of foreign DNA are not digested in the gut and might enter the organism or 
become incorporated into cells lining the gut wall (Doerfler, 2000; Tony et al., 2003).  
Transfer of the plant DNA to bacteria needs several steps, and the expectation seems to be 
extremely low (Kuiper et al., 2003; Sharma e al., 2004). Bacterial resistance to antibiotics is 
not a specific problem of genetic engineering. According to Directive 2001/18/EC, use of 
GMOs containing antibiotic-resistant genes will be forbidden starting from 01/01/2009 
(European Commission, 2001). 
Data are also available on the fate of recombinant plant DNA in the gastrointestinal tract of 
humans. By in vitro simulation of human digestion, 80% of the transgene in naked GM 
soybean DNA was degraded in the gastric simulations, while no degradation of the 
transgenes contained within GM soybean and corn was observed in these acidic conditions 
(Martin-Orúe et al., 2002). In the small intestinal simulations, transgenes in naked soybean 
DNA were degraded. In contrast, the corn nucleic acid was hydrolysed in the small 
intestinal simulations in a biphasic process in which approximately 85% was rapidly 
degraded, while the rest of the DNA was cleaved at a low rate of degradation.  
The number of transgene copies passing to the small intestine of human ileostomists 
consuming GM soya were successful quantified, and up to 3.7% of the transgene could 
survive passage (Neterwood et., 2004).  
Finally, another factor that will directly affect gene persistence throughout the digestive 
tract and therefore indirectly affect the chance of passage across the GIT epithelium is the 
digestibility of the ingested plant species. Feedstuffs with relatively greater digestibility, 
such as soybean meal, are likely to have their DNA degraded more rapidly, decreasing the 
chance of absorption.  
A low copy endogenous (soybean lectin) and recombinant (CP4 epsps) gene in longissimus 
dorsi muscle samples from pigs fed herbicide-tolerant soybean meal, in the grower and 
finisher phases, respectively were attempted to detect (Jennings et al., 2003). The same 
results about the fate of the CP4 epsps gene in other species were reported (Klotz & 
Einspanier, 1998).  
The CP4 epsps transgenic gene was not found in muscle and liver of chicken fed herbicide-
tolerant soybean up to 7 weeks after ingestion (Khumnirdpetch et al., 2001). According to 
the authors, GM soybean fragment were degraded in the gastrointestinal tract.  
As regards ruminants, chloroplast gene fragments were found in the leucocytes of dairy 
cows fed small quantities of transgenic soybean meal, while no fragments of the transgenic 
DNA were found in any tissue examined and in milk (Klotz & Einspanier, 1998). Similarly, 
high copy chloroplast “rubisco” gene fragments were found in the blood of cattle fed GM 
and soybean meal, but transgenic sequences were never detected (Phipps et al., 2003). 
In fish, soybean meal is used as dietary source of protein in their diet, however, because of 
the presence of anti-nutritional factors (ANFs) their inclusion levels should be kept low (Olli 
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et al., 1994). The fate of ingested GM soybean DNA fragments (120 and 195 bp) and a 180 bp 
fragment of the lectin gene of soybean in Atlantic salmon and their survival through the 
gastrointestinal tract (GIT) were investigated and the DNA was traced in a variety of fish 
tissues (liver, muscle and brain) (Sanden et al., 2004). Only the smaller GM DNA fragment 
(120 bp) was amplified from the content of the stomach, pyloric region, mid intestine and 
distal intestine, while no transgenic or conventional soybean DNA fragments were detected. 
The uptake of dietary DNA into blood, kidney and liver of salmon was investigated also by 
other authors (Nielsen et al., 2005) which determined the DNA fragment size if dietary DNA 
was detected. Most of the feed (partially digested) was found in the pyloric region, mid 
intestine, and distal intestine at 4, 8, and 16 h after force-feeding, while the highest 
concentrations of dietary DNA in liver and kidney were found 8 h after force-feeding, and 
blood up to 64 h. Finally, the cauliflower mosaic virus 35S promoter fragment (220 bp) of the 
GM defatted soybean meal was detected in the muscle of rainbow trout receiving both 
levels of GM soybean (approximately 15 and 30%) diet by nested PCR, but the frequency of 
detection was greater at the higher inclusion level (Chainark et al., 2006). Additionally, the 
promoter fragment was not detected by the fifth day after changing the diet to non-GM 
soybean. Conversely, the promoter fragment was not detected from fish fed with the non-
GM SBM diet. Successively, Chainark et al. (2008) traced foreign DNA fragments from 
genetically modified defatted soybean meal (GM SEM) in rainbow trout by nested 
polymerase chain reaction (PCR) and located by in situ hybridization. Either a GM or non-
GM SBM formulated diet (42% protein) was fed to fish (average weight 50.5 g) for 2 weeks. 
The degradation results showed that the cauliflower mosaic virus 35S promoter (220 bp) 
fragment was detected in the contents of digestive system only in fish fed the GM SBM diet, 
and it was not detected on the third day after changing the diet to the non-GM SBM diet. For 
the possible transferral results, the promoter fragment was detected in the leukocyte, head 
kidney and muscle only of fish fed the GM SBM diet; it was not detected on the fifth day 
after changing the diet to the non-GM SBM diet. These results suggest that a foreign DNA 
fragment was not completely degraded and might be taken up into organs through the 
gastrointestinal tract. However, foreign DNA was not detected after the withdrawal period. 
Thus, the data show that uptake of DNA from GM SBM might not remain in the tissues of 
fish fed GM SBM diet. Similarly, Ran et al. (2009) found DNA fragments from RR soybean in 
different tissues and organs of tilapias (Oreochromis niloticus, GIFT strain).  
Tudisco et al. (2006) in order to evaluate the presence of plant DNA fragments in tissues to 
follow the fate of plant fed,  carried out a research on twenty weaned 30-day-old New 
Zealand rabbits (10 males and 10 females), individually caged, which were equally assigned 
to control (C) and treated (T) groups. The animals were given a diet containing soybean 
meal (solved extracted) which was from conventional or Roundup Ready beans, for group C 
and T, respectively. The presence of chloroplast DNA was found in tissues and blood from 
both control and treated groups. The percentage of positive samples were: 50% (blood), 70% 
(muscle), 80% (heart), 70% (liver) and 80% (kidney). By contrast specific fragments of 
soybean were not detected in all samples but only in the plant samples. Similarly transgenic 
fragments gave undetectable results. 
Subsequently, the same authors (Tudisco et al. 2010) investigated the presence of DNA 
fragments in blood and milk from goats fed conventional (control) or Roundup Ready 
soybean and in blood, skeletal muscle and organs from their offspring. Transgenic target 
DNA sequences (35S and CP4 EPSPS) were detected in blood and milk from  goats that 
received a diet containing transgenic soybean as well as from some samples of their 
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offspring, not in the control group. Those findings show plant DNA fragments are likely to 
survive digestive processes to some extent (Duggan et al., 2003; Einspanier et al., 2004), as 
well as their transfer to blood and milk. In addition, the detection of plant DNA in tissues 
and organs of nursed kids could support the hypothesis of a gene transfer through milk.   
6. Effects on animal health of GM soybean  
In different experiments food and feed derived from GM plants, mixed in animal diets have 
been fed to rats, mice or other animal species during different periods of administration, and 
parameters such as body weight, feed consumption, blood chemistry, organ weights, 
histopathology, etc., have been measured. With respect to recent studies on safety 
assessment of GM soybeans, the scientific literature shows rather contradictory results. 
No immunotoxic activity or an increase in the IgE in serum and histopathological 
abnormalities were found in the mucosa of the small intestine of rats and mice fed heat-
treated GM soybean meal containing the cp4-epsps (Teshima et al., 2000). 
In Sprague–Dawley rats, Appenzeller et al. (2008) conducted a subchronic feeding study 
with the herbicide-tolerant soybean DP-356Ø43-5 (356043). Diets were fed to young adult 
animals for at least 93 days. Compared with rats fed with the isoline control or conventional 
reference diets, no biologically-relevant, adverse effects were observed in rats fed diets 
containing 356043 soybean with respect to body weight/gain, food consumption/efficiency, 
clinical signs, mortality, ophthalmology, neurobehavioral assessments (sensory response, 
grip strength and motor activity), clinical pathology (hematology, coagulation, serum 
chemistry and urinalysis), organ weights, and gross and microscopic pathology. Similarly, 
Delaney et al. (2008) carried out in Sprague–Dawley rats a subchronic feeding study of high 
oleic acid soybeans (Event DP-3Ø5423-1). DP-3Ø5423-1 (305423) is a GM soybean produced 
by biolistic insertion of a gm-fad2-1 gene fragment and the gm-hra gene into the germline of 
soybean seeds. Compared with rats fed the non-GM control diet, no biologically-relevant 
differences were observed in animals fed the 305423 diet with respect to body weight/gain, 
food consumption/efficiency, mortality, clinical signs of toxicity, or ophthalmologic 
observations. In addition, no diet-related effects were noted on neurobehavioral assessment, 
organ weights, or clinical or anatomic pathology. Based on the results of these studies, the 
authors concluded that 356043 and 305423 soybeans were as safe and nutritious as 
conventional non-GM soybeans. Sakamoto et al. (2007; 2008) conducted 52-week and 104-
week feeding studies of genetically modified soybeans in F344 rats. Although in both 
studies several differences in animal growth, food intake, serum biochemical parameters 
and histological findings were observed between rats fed the GM (glyphosate-tolerant) 
soybeans and those fed a commercial diet, body weight and food intake were similar for the 
rats fed the GM and non-GM soybeans. Gross necropsy findings, hematological and serum 
biochemical parameters, organ weights, and pathological findings showed no meaningful 
differences between rats fed the GM and non-GM soybeans. These results indicate that long-
term intake (54 and 104 weeks) of GM soybeans at the level of 30% in the diet had no 
apparent adverse effect in rats. 
In a 42-day feeding trial study conducted in broiler chickens (McNaughton et al., 2008), it 
was also concluded that 356043 soybean was nutritionally equivalent to non-transgenic 
control soybean with a comparable genetic background. 
Finally, also related to GM soybeans, Mathesius et al. (2009) assessed the safety of a 
modified acetolactate synthase protein (GM-HRA) used as a selectable marker in GM 
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soybeans. The authors did not find adverse effects in mice following acute oral exposure to 
GM-HRA at a dose of at least 436 mg/kg of body weight, or in a 28-day repeated dose 
dietary toxicity study at doses up to 1247 mg/kg of body weight/day. It was concluded that 
GM-HRA protein is safe when used in agricultural biotechnology. 
In contrast to the above results, in a long-term study on female mice fed with a GM 
modified soybean (insertion of the bacterial CP4 EPSPS gene to confer a high level of 
tolerance to glyphosate), focused on assessing the effects of this diet on liver of old animals 
(until 24 months of age) and to elucidate possible interference with aging, Malatesta et al. 
(2008a) found that GM soybean intake could influence the liver morpho-functional features 
during the physiological process of aging. Several proteins belonging to hepatocyte 
metabolism, stress response, calcium signaling and mitochondria were differentially 
expressed in GM-fed mice, indicating a more marked expression of senescence markers in 
comparison to controls. Moreover, hepatocytes of GM-fed mice showed mitochondrial and 
nuclear modifications indicative of reduced metabolic rate. In previous studies on 
hepatocytes from young and adult (2–8 months of age) female mice fed GM soybeans, 
nuclear modifications involving structural constituents of the transcription and splicing 
properties pathways were seen (Malatesta et al., 2002a). Although the cause(s) of the 
observed alterations could not be conclusively established, it was noted that these 
modifications disappeared when GM soybean was replaced by a non-GM one in the diet 
(Malatesta et al., 2005). Since the GM soybean used was tolerant to glyphosate and was 
treated with the glyphosate-containing herbicide Roundup, the effects observed might be 
due to herbicide residues. Accordingly, and aiming to verify this hypothesis, Malatesta et al. 
(2008b) treated rat hepatoma tissue culture (HTC) cells with 1–10 mM Roundup and 
analyzed cellular features by flow cytometry, fluorescence, and electron microscopy. Under 
these experimental conditions, the death rate and the general morphology of HTC cells were 
not affected, as well as most of the cytoplasmic organelles. However, in HTC-treated cells, 
lysosome density increased and mitochondrial membranes were modified indicating a 
decline in the respiratory activity. In addition to the above, nuclei underwent morpho-
functional modifications suggesting a decreased transcriptional/splicing activity. The 
authors did not exclude that factors other than the presence of the herbicide residues could 
be responsible for the cellular modifications described in GM-fed mice. However, they 
indicated that the concordance of the effects induced by low concentrations of Roundup on 
HTC cells suggested that the presence of Roundup residues could be one of the factors 
interfering with multiple metabolic pathways. 
Cisterna et al. (2008) investigated the ultrastructural and immunocytochemical features of 
pre-implantation embryos from mice fed either GM or non-GM soybean in order to verify 
whether the parental diet could affect the morpho-functional development of the embryonic 
ribonucleoprotein structural constituents involved in pre-mRNA pathways. Morphological 
observations revealed that the general aspect of embryo nuclear components were similar in 
the GM and non-GM soybean-exposed groups. However, immunocytochemical and in situ 
hybridization results suggested a temporary decrease of pre-mRNA transcription and 
splicing in 2-cell embryos and a resumption in 4–8-cell embryos from mice fed GM soybean. 
In addition, pre-mRNA maturation seemed to be less efficient in both 2-cell and 4–8-cell 
embryos from GM-fed mice than in non-GM-fed animals.  
Battistelli et al. (2010) investigated the duodenum and colon of mice fed on genetically 
modified (GM) soybean during their whole life span (1-24 months) by focusing their 
attention on the histological and ultrastructural characteristics of the epithelium, the 
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histochemical pattern of goblet cell mucins, and the growth profile of the coliform 
population. Even if the GM soybean-containing diet did not induce structural alterations in 
duodenal and colonic epithelium or in coliform population, the histochemical approach 
revealed significant diet-related changes in mucin amounts in the duodenum. In particular, 
the percentage of villous area occupied by acidic and sulphomucin granules decreased from 
controls to GM-fed animals. 
In a previous ultrastructural analysis of testes from mice fed GM soybean conducted by the 
same research group (Vecchio et al., 2004), it was found that the immunolabelling for Sm 
antigen, hnRNPs, SC35 and RNA Polymerase II was decreased in 2 and 5 month-old GM-
fed mice, and was restored to normal at 8 months. In GM-fed mice of all ages considered, 
the number of perichromatin granules was higher and the nuclear pore density lower. 
Moreover, enlargements in the smooth endoplasmic reticulum in GM-fed mice Sertoli cells 
were also observed. Consequently, all these studies  at the microscopic and ultramicroscopic 
levels showed cellular changes attributable to GM soybean intake. 
Magaña-Gómez et al. (2008) conducted a study in Wistar rats, in which the hypothesis was 
that the intake of GM (SUPRO 500E) soybean could induce pancreatic stress or injury by 
analyzing the expression of pancreatitis-associated protein (PAP) and trypsinogens by qRT-
PCR in rats fed GM soy protein for 30 days. The hypothesis was based on the results of 
previous investigations showing that mice chronically fed since gestation with GM had 
problems in synthesis and processing of zymogens by pancreatic acinar cells and reduced 
nucleoplasmic and nucleolar and perichromatin granule accumulation on pancreatic acinar 
cell nuclei (Malatesta et al., 2002b; 2003). Magaña-Gómez et al. (2008) did not find 
differences in nutritional performance among rats fed non-GM and GM diets. The GM diet 
induced significant zymogen-granule depletion after 15 days feeding, returning to normal 
levels after 30 days. Acinar disorganization started as early as 5 days after initiation of the 
GM diet and it recovered after 30 days. Levels of PAP mRNA significantly increased in the 
GM diet between day 1 and day 3 and decreased to the basal level by day 15. In turn, 
trypsinogen mRNA peaked at two different times: at day 1 and at day 15, decreasing to 
basal levels after 30 days, while plasma amylase levels remained unchanged at all times. The 
authors indicated that GM soy protein intake affected pancreas function, evidenced by the 
early acute PAP mRNA increased levels and pancreas cellular changes followed by 
recuperation of acinar cells after 30 days.  
Evaluating the GM soybean in Atlantic salmon diet, enlarged spleen and possible impaired 
spleen function as the number of smaller-sized red blood cells simultaneously increased 
were indicated (Hemre et al., 2005). 
The same authors (Sagstad et al., 2008) reported lower plasma triacylglycerol levels and a 
significantly larger spleen somatic index in fish groups fed GM soybean compared to groups 
fed non-GM soybean.  
Ermakova ( 2006) examined the effect of glyphosate-resistant (RR) GM soybean seeds fed to 
pregnant female rats on the number and weight of pups delivered The study was originally 
published in Russian, and was heavily criticised for using coated seeds ready for planting 
instead of beans suitable for feed. The control non-GM soybean was not the isogenic parent 
line, either. However, because of the possible serious implications of the results of this study 
for humans and animals it should have been repeated and possibly verified by other 
scientists with the correct GM soybean diets. Indeed, she has repeatedly pleaded for this but 
no one dared to try to reproduce her experiments. In this study rats were fed with 
laboratory rat chow and this diet was complemented with GM or conventional soybean for 
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two weeks before mating, during the pregnancy and during suckling and the body mass 
and the number of pups were observed. The data indicated that on the GM soybean-
supplemented rat chow significantly fewer pups were born, and with smaller body mass, 
than on the control non-GM soybeans. 
In order to evaluate the possible health effects of a GM diet, Tudisco et al (2006) studied the 
activity of organ specific enzymes in two groups of New Zealand rabbits, given a diet 
containing soybean meal which was from conventional or Roundup Ready beans.  
Statistical differences were detected in kidney for alanine aminotransferase (ALT), gamma 
glutamyltransferase (GGT) and lactic dehydrogenase (LDH) (higher activity for group fed 
GM soybean) whereas in the heart such result was seen only for LDH. No statistical 
differences were found for serum, liver and skeletal muscle. Significant differences between 
groups were detected for heart LDH1 and LDH2 and for kidney LDH1, thus confirming the 
significant increase of the enzyme in these tissues. Moreover, despite no significant 
differences were found for LDH total activity in liver, a significant increase (LDH1) and 
decrease (LDH4) were found also in this organ. 
Brasil et al. (2009) found that rats fed on GM soy showed altered morphology of the uterus 
and the ovaries: had greater volume density of endometrial glanular epithelium, reduced 
follicle number and increased corpus luteum numbers (a tendency to abort or less of a 
chance to get pregnant). Although the GM diet was not supplemented with cysteine as the 
other diets, and it is difficult to assess if the results were due to consumption of the 
transgenic soy itself or were due to the presence of glyphosate (and/or AMPA), always 
present in GM seeds, the findings are disturbing and warrant further studies.  
A recent study found that the hamsters fed with GM Soybean showed the growth of hairs 
inside the pouches of the mouth and the number of hairy mouthed hamsters was much 
higher in the third generation of GM soy fed animals than in others (Baranov et al., 2010). 
According to the authors, it remains unclear why these hair structures appear in the oral 
cavity of mammals. We may only speculate on the origin of this phenomenon. The gingival 
pouches may result from paradontitis and paradontosis caused by feeding on compound 
food in the vivarium, i.e., by a suboptimal diet. This pathology may be exacerbated by 
elements of the food that are absent in natural food, such as genetically modified (GM) 
ingredients (GM soybean or corn meal) or contaminants (pesticides, mycotoxins, heavy 
metals, etc.). Probably, hair growth in the gingival pouches is a protective reaction of the 
body suppressing the progress of gingival pathology, because the hair bundles are so dense 
that they prevent food from getting into the pouches and the resultant inevitable 
inflammation. Hair grows in the parts of the mucosa that, being affected by mechanical 
factors, acquire the capacity for keratinization.  
More recently, Tudisco et al  (2010) studied the possible effects on cell metabolism,  by 
determination of several specific enzymes in serum of goats fed conventional or Roundup 
Ready soybean and in  heart, skeletal muscle, liver and kidney of their offspring. Aspartate 
aminotransferase (AST) and ALT enzyme activity were significantly lower in serum from 
goats fed GM soybean but enzyme levels were in the normal range. Statistical differences 
were detected in kid’s kidney for GGT and LDH, whereas in the heart and skeletal muscle 
this result was seen only for LDH. The increase in LDH activity was confirmed by 
histochemistry. In addition, significant differences between control and treated animals 
were detected for heart, kidney, muscles and liver LDH isoenzyme distribution, particularly 
concerning the LDH1, as found previously in the rabbits. Since LDH1 is known to be 
involved in cell metabolism by favouring the reaction of lactate to pyruvate (Van Hall, 2000), 
these results could indicate a general increase in cell metabolism.  
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A summary of experimental studies concerning health of animals fed genetically modified 
soybean is reported in Table 4. 
 
Animal 
species 
Length of 
study 
Main effects Reference 
BN rats and 
B10A mice 
15 weeks 
No immunotoxic activity. No 
histopathological abnormalities. 
Teshima et al. 
(2000) 
Sprague–
Dawley rats 
> 93 days 
No adverse effects on body 
weight/gain, food consumption, clinical 
signs, mortality, ophthalmology, 
neurobehavioral assessment, clinical 
pathology, organ weights and gross and 
microscopic pathology 
Appenzeller et 
al. (2008) 
Sprague–
Dawley rats 
– 
No adverse effects on body 
weight/gain, food consumption, and 
mortality, clinical signs of toxicity or 
ophthalmological observations, 
neurobehavioral assessments, organ 
weights or clinical and anatomic 
pathology 
Delaney et al. 
(2008) 
Mice 28 days No adverse effects 
Mathesius et 
al. (2009) 
F344 rats 52 weeks 
No adverse effect in gross necropsy 
findings, hematological and serum 
biochemical parameters, organ weights 
and pathological findings 
Sakamoto et 
al. (2007) 
F344 rats 104 weeks 
No adverse effect in gross necropsy 
findings, hematological and serum 
biochemical parameters, organ weights 
and pathological findings 
Sakamoto et 
al. (2008) 
Broilers 42 days 
No adverse effects were found. It was 
concluded that GM 356Ø43 was 
nutritionally equivalent to non-GM 
soybean with comparable genetic 
background 
McNaughton 
et al. (2008) 
Mice - 
Enlargements in the smooth 
endoplasmic reticulum of Sertoli cells 
Vecchio et al. 
(2004) 
Mice – 
Several proteins belonging to hepatocyte 
metabolism, stress response, calcium 
signaling and mitochondria were 
differentially expressed in GM-fed mice 
indicating a more marked expression of 
senescence markers in comparison to 
controls. GM-fed mice showed 
mitochondrial and nuclear modifications 
indicative of reduced metabolic rate 
Malatesta et al. 
(2008a) 
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Mice – 
No morphological differences in 
embryos of GM and non-Gm soybean-
exposed groups. Microscopic and 
ultramicroscopic cellular changes 
attributed to GM soybean intake 
Cisterna et al. 
(2008) 
Wistar rats 30 days 
No adverse effects in nutritional 
performance. Altered pancreas function 
evidenced by the early acute PAP 
mRNA increased levels and pancreas 
cellular changes 
(Malatesta et 
al., 2002a) and 
(Malatesta et 
al., 2002b) 
Wistar rats 30 days Significant zymogen-granule depletion 
Magaña-
Gómez et al. 
(2008) 
Pregnant Rats 2 weeks 
Fewer pups born with smaller body 
mass 
Ermakova et 
al. (2006) 
Rabbits 60 days 
Significant alteration of kidney ALT, 
GGT and LDH activity. Significant 
alteration of heart LDH activity 
Tudisco et al. 
(2006) 
Hamsters - 
Growth of hairs inside the pouches of 
the mouth and the number of hairy 
mouthed 
Baranov et al. 
(2010) 
Kids 60 days 
Significant alteration of kidney GGT 
and LDH activity. Significant alteration 
of LDH isoenzyme distribution in heart, 
kidney, muscle and liver 
Tudisco et al. 
(2010) 
Table 4. A summary of experimental studies concerning health of animals fed with 
genetically modified soybean. 
7. Human/animal safety of glyphosate 
Glyphosate is not a genetically modified product but because its use in agriculture is 
inseparable from the cultivation of herbicide-tolerant GM crops in a particular technology 
package, its effects on health need to be examined also with that of the glyphosate-resistant 
GM crops. Although the declared aim of the introduction of glyphosate resistant GM crops 
was that with these crops the amount of herbicide sprayed on the land should decrease, due 
to the ever increasing area of cultivation of glyphosate-resistant Roundup Ready GM crops, 
the use of glyphosate has in fact increased (Benbrook, 2004; 2009). The glyphosate-
containing sprays destroy all weeds but the growth of the glyphosate-resistant GM crop is 
protected regardless of how much glyphosate is sprayed on to the land. To make sure that 
all weeds are destroyed the use of glyphosate and consequently the glyphosate load of the 
land has been substantially increasing after the first few years of a slight reduction 
(Benbrook, 2004; 2009). This has happened despite the ever-increasing number of 
publications showing that glyphosate has many serious and detrimental effects on the 
environment and biodiversity (Relyea 2005) with the development of herbicide-resistant 
weeds (Duke, 2005; Owen & Zelaya 2005; Warwick et al., 2008; Zelaya et al., 2007). There is 
also an urgent need to consider the potentially seriously damaging effects of this total 
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herbicide on human/animal health, particularly as it is used in large amounts. Indeed, there 
are a  number of recently published papers that all indicate possible damaging effects of 
glyphosate on health and reproduction which need to be taken seriously. On previous work 
the findings of Marc et al. (2005) have confirmed and extended their previous results by 
showing that the main ingredient of commercial Roundup formulations, glyphosate, in a 
mM concentration range, particularly when used together with the obligatory 
polyoxyethylene amine surfactant, inhibited the transcription of one of the enzymes 
involved in hatching of sea urchin embryos and therefore significantly delayed their 
hatching. When it is considered that farm workers inhale commercial herbicide sprays in 
which the active ingredient concentration exceeds by about 25 times of that used in the 
transcription inhibition studies by Marc et al. (2005), health concerns due to the use of 
glyphosate must be acute. In another study it was shown that in the oral treatment of Wistar 
rats with increasing concentrations of the herbicide Glyphosate-Biocarb, a formulation used 
in many countries such as Brazil, the number of Kupffer cells in hepatic sinusoids increased, 
followed by large deposition of reticulin fibres and the leakage of hepatic aspartate 
aminotransferase and alanine aminotransferase into the circulation, indicating hepatic 
damage in these animals (Benedetti et al., 2004). Successively, Richard et al. (2005) and 
Benachour et al. (2007) showed that glyphosate, particularly as used together with 
polyoxyethylene amine surfactant in Roundup Ready formulations, was toxic to human 
placental JEG3 cells at concentrations lower than that used in agricultural practices. Even at 
subtoxic concentrations RR was an endocrine disruptor on aromatase activity and its mRNA 
level as glyphosate interacted with the active site of the purified enzyme. It is possible that 
the pregnancy problems in agricultural workers using Roundup may be traced back to the 
exposure to this herbicide (Savitz et al., 2000).  
Recently, Gasnier et al. (2009)  exposed human liver HepG2 cells, a well-known model to 
study xenobiotic toxicity, to four different formulations and to glyphosate, which is usually 
tested alone in chronic in vivo regulatory studies. They measured cytotoxicity with three 
assays (Alamar Blue®, MTT, ToxiLight®), plus genotoxicity (comet assay), anti-estrogenic 
(on ER_, ER_) and anti-androgenic effects (on AR) using gene reporter tests. They  also 
checked androgen to estrogen conversion by aromatase activity and mRNA. All parameters 
were disrupted at sub-agricultural doses with all formulations within 24 h. These effects 
were more dependent on the formulation than on the glyphosate concentration. First, the 
observed a human cell endocrine disruption from 0.5ppm on the androgen receptor in 
MDA-MB453-kb2 cells for the most active formulation (R400), then from 2ppm the 
transcriptional activities on both estrogen receptors were also inhibited on HepG2. 
Aromatase transcription and activity were disrupted from 10 ppm. Cytotoxic effects started 
at 10ppm with Alamar Blue assay (the most sensitive), and DNA damages at 5 ppm.  
According to the authors, the direct G action is most probably amplified by vesicles formed 
by adjuvants or detergent-like substances that allow cell penetration, stability, and probably 
change its bioavailability and thus metabolism. These detergents can also be present in 
rivers as polluting contaminants. The type of formulation should then be identified precisely 
in epidemiological studies of G-based herbicides effects. Of course to drive hypotheses on in 
vivo effects, not only dilution in the body, elimination, metabolism, but also bioaccumulation 
and time-amplified effects should be taken into account. These herbicides mixtures also 
present endocrine effects on human cells, at doses far below agricultural dilutions and toxic 
levels on mitochondrial activities and membrane integrity.  
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All these findings indicate that there is an urgent need to carry out systematic and direct 
studies, independent of the biotech industry, on the short- and long-term effects on animal 
(and human) health of exposure to glyphosate and its more effective commercial 
formulations alone and/or preferably in combination with the appropriate GM crop. With 
the presently cultivated huge areas of Roundup Ready crops and the anticipated even larger 
future extensions of this glyphosate-dependent GM crop technology the potential danger for 
animal/human health needs to be dealt with in advance and not if or when it occurs. If we 
consider that RR soybeans may in themselves damage reproduction, a combination of the 
similar, possibly synergistic effects of the GM crop and glyphosate could be a potential 
disaster waiting to happen.  
8. Conclusions 
The debate on the safety of genetically modified organisms (GMOs) used for food and feed 
is still very lively throughout the world, more than 15 years after their first commercial 
release. Huge social, economical, and political issues have been raised. Unfortunately, 
although some stakeholders claim that a history of safe use of GMOs can be upheld, there 
are no human or animal epidemiological studies to support such a claim as yet, in particular 
because of the lack of labeling and traceability in GMO-producing countries. As a matter of 
fact, 97% of edible GMOs among cultivated GMOs (soy, corn and oilseed rape or canola, 
excluding cotton) are grown in South and North America, where GMOs are not labeled. All 
these plants have been modified to tolerate and/or produce one or more pesticides, and 
contain therefore such residues at various levels. Most are Roundup residues (it is a major 
herbicide used worldwide and tolerated by about 80% of GMOs). 
As stated by the EFSA (2008), several aspects have to be investigated when considering 
whether or not recombinant DNA from GM plants, or the derived proteins can end up in 
animal tissues and products. These include (i) the fate of the recombinant DNA and protein 
during feed processing and ensiling; (ii) the fate of the recombinant DNA and protein in the 
gastrointestinal tract of animals fed with GM feed; (iii) the potential absorption of the 
digested pieces of DNA or protein into animal tissues/products and (iv) the potential of 
biological functionality of absorbed DNA and protein fragments. 
The mere detection of recombinant DNA fragments in animal organs and tissues could not 
justify, by itself, public concerns regarding human consumption of products from farm 
animals fed transgenic crops. However, the persistence of DNA after dietary exposure is one 
aspect of risk assessment for novel food. Indeed, as concerns the hypothetical horizontal 
gene transfer of recombinant DNA from GM crop-derived feeds to animal and human gut 
microflora, Netherwood et al. (2004), found that a small proportion of feed DNA survives 
passage through the human upper gastrointestinal tract and a very small proportion of the 
small intestinal microflora containing transgenic feed. According to the authors, even if this 
result does not indicate a complete transgenic transfer to the prokaryotes, the survival of  
transgenic DNA during the passage through the small intestine should be considered in 
future safety assessments of GM foods. In addition, any alteration in cell metabolism should 
be taken into account in this field. For instance, the modification in LDH synthesis suggests 
an increase in cell metabolism. Therefore, possible long-term effects of such an alteration 
need to be elucidated.  
In conclusion, taking into account the potential risks related to GMP impact, further 
researches are needed in this area, including studies to determine DNA transport or entry 
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mechanisms/processes across the epithelial layer of the gastro-intestinal tract into the 
bloodstream, as well as degradation or accumulation of foreign DNA in blood or other 
organs of animal species. In any case, the traceability of products from animals fed on 
GMOs is crucial.  
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